Navigation Links
Cancer Vaccines: From First-in-Class to Best-in-Class?
Date:4/9/2013

cules 389
9.1.1 Background 389
9.1.2 Target Strategies of Small Molecule Drugs 390
9.2 Peptide & Protein Drugs 392
9.2.1 Background 392
9.2.2 Target Strategies of Peptide and Protein Drugs 393
9.3 Antibodies 400
9.3.1 Background 400
9.3.2 Target Strategies of Antibody Drugs 400
9.4 Nucleic Acid Therapies 403
9.4.1 Background 403
9.4.2 Target Strategies of Nucleic Acid Drugs 404
9.5 Cell & Gene Therapy 407
9.5.1 Background 407
9.5.2 Target Strategies of Cell and Gene Therapy Drugs 408
10 The Competition Through Close Mechanistic Approximation of Cancer Vaccine Drugs 414
11 Selecting Indications for Cancer Vaccine Drugs 417
11.1 Acute Lymphocytic Leukemia 420
11.2 Acute Myelogenous Leukemia 421
11.3 Acute Promyelocytic Leukemia 423
11.4 Anal Dysplasia 424
11.5 B-cell Lymphoma 425
11.6 Biliary Cancer 426
11.7 Bladder Cancer 427
11.8 Bone Cancer 428
11.9 Brain Cancer 429
11.10 Breast Cancer 431
11.11 Cancer (general) 434
11.12 Cervical Cancer 435
11.13 Cervical Dysplasia 438
11.14 Chronic Myelogenous Leukemia 440
11.15 Colorectal Adenoma 441
11.16 Colorectal Cancer 442
11.17 Endometrial Cancer 445
11.18 Fallopian Tube Cancer 446
11.19 Gastrointestinal Cancer (general) 447
11.20 Gastrointestinal Stomach Cancer 448
11.21 Glioma 449
11.22 Head and Neck Cancer 450
11.23 Hematological Cancer (general) 452
11.24 Leukemia (general) 453
11.25 Liver Cancer 454
11.26 Lung Cancer (general) 455
11.27 Lymphoma (general) 458
11.28 Melanoma 459
11.29 Merkel cell carcinoma 462
11.30 Mesothelioma 463
11.31 Myelodysplastic Syndrome 464
11.32 Myeloma 465
11.33 non-Hodgkin's Lymphoma 466
11.34 Non-Small Cell Lung Cancer 467
11.35 Oesophageal Cancer 469
11.36 Osteo Sarcoma 470
11.37 Ovarian Cancer 471
11.38 Pancreatic Cancer 473
11.39 P
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
2. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
3. Take the Skyhook Challenge and Help Beat Blood Cancer
4. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
5. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
6. Penn Medicines New Center For Personalized Diagnostics Unlocks Cancers Secrets
7. Cerulean Pharma to Present Data on CRLX101s HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
8. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
9. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
10. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
11. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Wash. and VANCOUVER , ... OGXI ) announced today that it will report its ... 2015. Company management will host a conference call and ... an overview of financial results, clinical development programs and ... the webcast, log on to the Investor Relations page ...
(Date:7/30/2015)... OAKS, Calif. , July 30, 2015  Amgen (NASDAQ: ... Hassan , partner and managing director of Warburg Pincus LLC, ... are pleased to welcome Fred Hassan and the ... the Amgen Board," said Robert A. Bradway , chairman ... and commitment to innovation will serve Amgen well." ...
(Date:7/30/2015)... 30, 2015 Eisai Inc. announced today that ... United States , European Union and ... respectively) for eribulin, for the treatment of patients with ... chemotherapy for advanced or metastatic disease. ... pivotal global Phase 3 clinical trial (Study 309), which ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
(Date:8/1/2015)... Greenwich, CT (PRWEB) , ... August 01, 2015 ... ... Great Point Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy ... incorporating it into its portfolio of state-of-the-art clinics. , “Our acquisition of Premier ...
(Date:8/1/2015)... ... , ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for ... by stepping off Springer Mountain and heading north. Since that day, Phil has hiked over ... was greeted by friends and family. He visited CCAR and left an inspirational message ...
(Date:7/31/2015)... ... 2015 , ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, ... is the Super Bowl. In the two weeks that separate the conference championships and the ... 2016 Super Bowl game will mark the 50th time it has been held and the ...
(Date:7/31/2015)... ... ... The 2nd annual Ride to Fight On will start and end near the ... to Fight On is a cycling fundraiser that benefits the West Cancer Center, a ... University of Tennessee Health Science Center. A health and wellness festival featuring food, music, ...
(Date:7/31/2015)... Mountain View, CA (PRWEB) , ... July 31, 2015 , ... ... hand for the athletes, judges, media, and VIPs at the 2015 Vans US Open ... best-tasting organic coconut water that can claim “no added sugar” on the market, is ...
Breaking Medicine News(10 mins):Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2
... Feb. 10 B. Braun Medical Inc. (B. ... pain management as well as a pioneer in ... announced today that it has been awarded a ... both hemodialysis and continuous renal replacement therapy (CRRT) ...
... Hospitals Help Set Unprecedented NumbersVIRGINIA BEACH, Va., Feb. ... was able to save the lives of 406 ... in 2008.LifeNet Health saw a 13% increase from ... supplied to hospitals and physicians. LifeNet Health ...
... Valentine,s Day often includes expensive dinners and fattening candy ... of a recent American Heart Association survey suggest couples ... -- walks on the beach, in a park and ... connected with their significant other while on a walk ...
... SurgiQuest, Inc. AirSeal Dynamic Pressure System(TM) was ... AirSeal DPS(TM) continuously re-circulates and filters CO2 used ... routinely have to interrupt laparoscopic surgical procedures due ... plume within the operative environment. This impairment restricts ...
... Industry Leaders Team up to Drive Performance Improvements ... ( www.activplant.com ) announced today that GlaxoSmithKline PLC ... Activplant as a recommended business intelligence solution for ... a successful implementation where GSK experienced the ease ...
... LLC, as the new publishing company for JNCCN - ... Spring Publishing is a newly formed medical publishing company ... Conor Lynch. Content in JNCCN covers the entire spectrum ... Clinical Practice Guidelines in Oncology(TM).FORT WASHINGTON, Pa., Feb. 10 ...
Cached Medicine News:Health News:B. Braun Wins Premier Contract for Full Line of Dialysis Products 2Health News:B. Braun Wins Premier Contract for Full Line of Dialysis Products 3Health News:LifeNet Health Announces a Record Year of Saving Lives and Restoring Health 2Health News:LifeNet Health Announces a Record Year of Saving Lives and Restoring Health 3Health News:American Heart Association Survey: Romance and Walking a Perfect Match 2Health News:SurgiQuest Announces FDA Approval for Smoke & Plume Evacuation for AirSeal Dynamic Pressure System(TM) 2Health News:Activplant Corporation Announces Global Agreement with GlaxoSmithKline 2Health News:JNCCN Names New Publishing Company 2Health News:JNCCN Names New Publishing Company 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: